5-Pyrimidinecarbothioamide,1,2,3,4-tetrahydro-1-(1-methylethyl)-2,4-dioxo-3-(phenylmethyl)- (175203-49-3)

Identification
Name:	5-Pyrimidinecarbothioamide,1,2,3,4-tetrahydro-1-(1-methylethyl)-2,4-dioxo-3-(phenylmethyl)-
Synonyms:	3-BENZYL-1-ISOPROPYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOTHIOAMIDE;3-BENZYL-1-ISOPROPYLURACIL-5-THIOCARBOXAMIDE
CAS:	175203-49-3
Molecular Formula:	C15H17 N3 O2 S
Molecular Weight:	303.38
InChI:	InChI=1/C15H17N3O2S/c1-10(2)17-9-12(13(16)21)14(19)18(15(17)20)8-11-6-4-3-5-7-11/h3-7,9-10H,8H2,1-2H3,(H2,16,21)
Molecular Structure:
Properties
Melting Point:	173 °C
Flash Point:	226°C
Boiling Point:	450.1°Cat760mmHg
Density:	1.321g/cm³
Refractive index:	1.651
Flash Point:	226°C
Safety Data

Other Product

5-Pyrimidinecarbothioamide,6-amino-1,2,3,4-tetrahydro-1-(2-methylpropyl)-2,4-dioxo-N-(phenylmethyl)-
5-Pyrimidinecarbothioamide,6-amino-N-(4-chlorophenyl)-1,2,3,4-tetrahydro-1-methyl-2,4-dioxo-
5-Pyrimidinecarbothioamide,6-amino-1-(4-chlorophenyl)-N-ethyl-1,2,3,4-tetrahydro-2,4-dioxo-
5-Pyrimidinecarbothioamide,6-amino-N-ethyl-1,2,3,4-tetrahydro-2,4-dioxo-1-(phenylmethyl)-
5-Pyrimidinecarbothioamide,4-amino-, hydrate (1:1)
2-Pyrimidinecarbothioamide, 4-[3-(aminothioxomethyl)phenyl]-
5-Pyrimidinecarbothioamide,6-amino-1,2,3,4-tetrahydro-N-methyl-2,4-dioxo-1-phenyl-
1(2H)-Pyrimidineacetamide,N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-, (aS)-
2-Furancarboxaldehyde, 5-(3-chlorophenyl)-,methyl[1,2,3,6-tetrahydro-2,6-dioxo-1-[1-(phenylmethyl)-4-piperidinyl]-4-pyrimidinyl]hydrazone
5-Pyrimidinecarbothioamide,6-amino-1,3-diethyl-1,2,3,4-tetrahydro-N-methyl-4-oxo-2-thioxo-
1H-1,5-Benzodiazepine-1-acetamide,2,3,4,5-tetrahydro-N-(4-methoxyphenyl)-N-(1-methylethyl)-2,4-dioxo-3-(phenylhydrazono)-5-(2-pyrimidinyl)-
1H-1,5-Benzodiazepine-1-acetamide,2,3,4,5-tetrahydro-N-(4-methoxyphenyl)-N-(1-methylethyl)-2,4-dioxo-3-(phenylhydrazono)-5-(2-pyridinyl)-
1H-1,5-Benzodiazepine-1-acetamide,3-amino-2,3,4,5-tetrahydro-N-(4-methoxyphenyl)-N-(1-methylethyl)-2,4-dioxo-5-(2-pyridinyl)-
1H-1,5-Benzodiazepine-1-acetamide,3-amino-2,3,4,5-tetrahydro-N-(4-methoxyphenyl)-N-(1-methylethyl)-2,4-dioxo-5-(2-pyrimidinyl)-
5-Pyrimidinecarbothioamide,4-amino-
2-Propenoic acid,3-[1-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-deoxy-b-D-erythro-pentofuranosyl]-1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl]-,methyl ester
1H-1,5-Benzodiazepine-1-acetamide,2,3,4,5-tetrahydro-N-(4-methoxyphenyl)-N-(1-methylethyl)-3-[[3-methyl-1-(phenylmethyl)-1H-pyrazol-5-yl]methyl]-2,4-dioxo-5-phenyl-
1H-1,5-Benzodiazepine-1-acetamide,2,3,4,5-tetrahydro-N-(4-methoxyphenyl)-3-methyl-N-(1-methylethyl)-2,4-dioxo-5-phenyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]methyl]-
3-Oxazolidinecarboxylicacid, 4-(1-methylethyl)-2,5-dioxo-, phenylmethyl ester, (4S)-
2-Pyrazinecarboxamide,N-(6-amino-1,2,3,4-tetrahydro-2,4-dioxo-1,3-dipropyl-5-pyrimidinyl)-3-[[4-(phenylmethyl)-1-piperidinyl]carbonyl]-